Soo Hyeon Bae Selected Research

sophoranone

1/2015

Pharmacokinetic properties of trifolirhizin, (-)-maackiain, (-)-sophoranone and 2-(2,4-dihydroxyphenyl)-5,6-methylenedioxybenzofuran after intravenous and oral administration of Sophora tonkinensis extract in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soo Hyeon Bae Research Topics

Disease

2	Neoplasms (Cancer) 10/2017 - 12/2012
1	Schizophrenia (Dementia Praecox) 01/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2020
1	Alopecia Areata 06/2019
1	Twenty-Nail Dystrophy 06/2019
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Retinoblastoma (Glioblastoma, Retinal) 10/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017
1	Rosacea (Acne Rosacea) 12/2016
1	Asthma (Bronchial Asthma) 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Exanthema (Rash) 09/2014
1	Eosinophilia 09/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2014
1	Colonic Neoplasms (Colon Cancer) 12/2012

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2015 - 12/2012
1	Clozapine (Clozaril)FDA LinkGeneric 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Liposomes (Liposome)IBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	Small Interfering RNA (siRNA)IBA 10/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2017
1	Toll-Like Receptor 2IBA 12/2016
1	CathelicidinsIBA 12/2016
1	Kallikreins (Kallikrein)IBA 12/2016
1	Peptide Hydrolases (Proteases)FDA Link 12/2016
1	inerminIBA 01/2015
1	sibutramine (Meridia)FDA Link 01/2015
1	sophoranoneIBA 01/2015
1	trifolirhizinIBA 01/2015
1	Immunoglobulin E (IgE)IBA 09/2014
1	U 0126 (UO 126)IBA 12/2012

Therapy/Procedure

2	Therapeutics 10/2017 - 09/2014
1	Drug Therapy (Chemotherapy) 10/2017
1	Lasers (Laser) 12/2016
1	Aftercare (After-Treatment) 01/2015